Over at Living the Scientific Life, GrrlScientist has a blog post on the puffed-up importance of journal impact factors and the "rampant citation bartering among scientists" that has resulted from it. GrrlScientist contends that impact factors are by no means a good way to measure the accuracy of any individual paper, and expounds on the problems that have ensued from scientists' focusing too much on publishing in journals with high impact factors.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.